Learning Lessons from Adverse Drug Reactions in Children
Helen M Sammons1, Imti Choonara2
1University of Nottingham, Division of Medical Sciences and Graduate Entry Medicine, Derbyshire Children's Hospital, Derby DE22 3DT, UK. helen.sammons@nottingham.ac.uk.
Children (Basel, Switzerland)
|July 16, 2016
Summary
Pediatric drug toxicity is a significant issue, with higher risks in hospitalized children. Understanding adverse drug reaction mechanisms is key to reducing harm in children.
Area of Science:
- Pediatric Pharmacology
- Clinical Toxicology
- Drug Safety in Children
Background:
- Adverse drug reactions (ADRs) pose a significant health risk to children, both in community and hospital settings.
- Pediatric drug toxicity differs from adult toxicity, with unique reactions observed in younger age groups, notably neonates.
- Approximately 1 in 500 children experience an ADR annually, escalating to 1 in 10 for hospitalized children.
Purpose of the Study:
- To highlight the prevalence and unique aspects of drug toxicity in pediatric populations.
- To emphasize the importance of understanding the mechanisms behind adverse drug reactions in children.
- To advocate for rational prescribing practices to mitigate pediatric drug toxicity.
Main Methods:
- Literature review and analysis of existing data on pediatric drug toxicity.
- Examination of historical cases and epidemiological data concerning adverse drug reactions in children.
- Discussion of the mechanistic basis of drug toxicity in various pediatric age groups.
Main Results:
- Children experience adverse drug reactions at a notable rate, with hospitalized children facing significantly higher risks.
- Specific and unique adverse drug reactions are prevalent in pediatric patients, including neonates.
- Current understanding of adverse drug reaction mechanisms in children is insufficient for optimal prevention.
Conclusions:
- Pediatric drug toxicity is a critical issue requiring focused attention and research.
- A deeper comprehension of adverse drug reaction mechanisms is essential for developing effective interventions.
- Rational prescribing and enhanced understanding are crucial for reducing drug toxicity in the pediatric population.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
360
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
423
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
423
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
313
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
645
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
645
01:29Drug Dosing: Infants and Children
692
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
692
01:24Drug Toxicity: Risk factors
111
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
111